Option Care Health, Inc.

Option Care Health, Inc. is the largest independent provider of home and alternate-site infusion services in the United States. Headquartered in Bannockburn, Illinois, the company's core business revolves around delivering high-quality, cost-effective infusion therapy to patients with acute and chronic conditions outside of traditional hospital settings. Its mission is to transform healthcare by providing innovative services that improve outcomes, reduce costs, and deliver hope for patients and their families, guided by a purpose to provide extraordinary care that changes lives.

The company offers a comprehensive portfolio of services, including the administration of anti-infectives, nutrition support (home parenteral and enteral), immunoglobulin infusion therapies, and specialized treatments for complex conditions. Option Care Health addresses a wide range of medical needs, such as bleeding disorders, neurological disorders, heart failure, and chronic inflammatory disorders. These services are delivered through a national network of infusion suites and in patients' homes, emphasizing personalized care plans.

Led by President and CEO John C. Rademacher, Option Care Health maintains its position as a market leader, capitalizing on the ongoing shift from hospital-based care to more cost-effective home and alternate-site settings. In recent financial news, the company reported full-year 2025 net revenue of $5,649.5 million, marking a 13.0% increase, and first-quarter 2026 net revenue of $1,350.7 million. Option Care Health was recognized as No. 15 on the World's Most Impactful Companies 2026 list in June 2026. Despite its strong market position, the company faces ongoing pressures from biosimilar conversions and reimbursement dynamics, alongside managing a notable debt level.